(Q38330186)

English

RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Hirotoshi Kawata

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Naoki Shimada

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Tomoko Kamiakito

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Kenji Komatsu

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Tatsuo Morita

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Toshio Ota

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Masaya Obayashi

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Kenya Shitara

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Akira Tanaka

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

14 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

72

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1071-1079

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Androgen receptor in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Identification of androgen-responsive genes that are alternatively regulated in androgen-dependent and androgen-independent rat prostate tumors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate-specific antigen expressions

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Mammalian Rho GTPases: new insights into their functions from in vivo studies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

GEFs and GAPs: critical elements in the control of small G proteins

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

RHO-GTPases and cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Epithelium-mesenchyme: a balancing act of RhoGAP and RhoGEF.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Epithelial-mesenchymal transitions in development and disease

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Purification of activins from androgen-independent Shionogi carcinoma cells demonstrates enhanced expression of activin betaB-subunit under androgen-depleted cell conditions in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

The Rho exchange factor Net1 is regulated by nuclear sequestration

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

FGF-8 is involved in bone metastasis of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

A neutralizing anti-fibroblast growth factor 8 monoclonal antibody shows potent antitumor activity against androgen-dependent mouse mammary tumors in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Genomic analysis of metastasis reveals an essential role for RhoC

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

RhoC Promotes Metastasis via Activation of the Pyk2 Pathway in Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

The morphological and molecular features of the epithelial-to-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21511

21 January 2018

Identifiers

10.1002/PROS.21511

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38330186&oldid=1766993206"